Facebook
X
LinkedIn
ForwardSymposium Session: Life After GLP-1 Agonist Therapy for Weight Loss
There are several critical aspects of patient care and management following the discontinuation of GLP-1 receptor agonist therapy for weight loss, including weight regain, increased appetite and cravings, changes in body composition, and the potential for medication reinitiation.
In this case study-based session, Dr. Su-Nui Escobar will explore the latest evidence on weight management and practical observations from clinical practice. Designated specially for practitioners working as part of a care team, attendees will gain comprehensive insights into effective post-therapy nutrition and wellness strategies that support long-term weight stability
as well as effective care team collaboration.
This is not a webinar or course for purchase - this is a module for credit claiming for our 2025 Spring Symposium attendees and cannot be purchased or taken by non-attendees. These sessions are exclusive to our Symposium; however, the topics may be revisited in the future in the form of a webinar or self-study course.
Learning Objectives
After completing this continuing education activity, health care professionals will be better able to:
- Review the data and evidence-base surrounding weight regain trends following the cessation of semaglutide and tirzepatide.
- Explore the factors that influence weight regain after treatment discontinuation.
- Discuss practical nutrition and wellness strategies that help mitigate weight regain risks.
- Implement patient counseling approaches across the heath care team for sustaining long-term weight management outcomes.
Additional Information
Dr. Su-Nui Escobar, DCN, RDN, FAND, is a doctor in clinical nutrition and a registered dietitian nutritionist with a passion for helping individuals on GLP-1 medications optimize their weight loss journey. Recognizing the unique nutritional needs and challenges faced by those taking weight loss medications, Dr. Escobar combines her extensive experience counseling patients with her expertise as a dietitian and researcher.
In addition to her work with patients, Dr. Escobar has spoken at national conferences, training other health care professionals on nutrition for these medications. She has also taught nutrition at Nova Southeastern University’s Dr. Kiran C. Patel College of Osteopathic Medicine and is a former spokesperson for the Academy of Nutrition and Dietetics.
DISCLOSURES
The faculty and planners of this educational activity have no relevant financial relationships with ineligible companies to disclose.
An “ineligible company” includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, Great Valley Publishing Company is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity will also award credit for dietetics (CDR CPEU).
RDs and DTRs are to select activity type 102 in their Activity Log. Sphere and Competency selection is at the learner’s discretion.
Physicians: Great Valley Publishing designates this live material for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.25 Interprofessional Continuing Education (IPCE)This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credits for learning and change.